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alivary  gland  carcinosarcoma  is  an  exceedingly  rare  and
ggressive  neoplasm  composed  of  a  mixture  of  carcinoma-
ous  and  sarcomatous  components,  with  either  component
apable  of  metastasis.  Salivary  gland  carcinosarcoma  can
rise  in  pleomorphic  adenoma  (PA)  or  de  novo.1
The  present  study  reports  a  case  of  the  parotid  gland  de
ovo  carcinosarcoma,  which  contained  salivary  duct  adeno-
arcinoma  and  sarcoma  that  resembled  malignant  ﬁbrous
istiocytoma  (MFH).  To  the  authors’  knowledge,  MFH  as
 component  of  salivary  gland  carcinosarcoma  has  been
escribed  only  once  in  literature,  and  was  combined  with
quamous  cell  carcinoma.2
ase presentation 45-year-old  man  presented  with  a  mass  in  the  right  parotid
land  that  had  been  rapidly  enlarging  for  eight  weeks.  Pre-
perative  ultrasound  showed  a  tumor  in  the  parotid  gland
ut  without  sign  of  metastasis  in  regional  lymph  nodes.
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eserved.he  patient  underwent  right  total  parotidectomy,  and  gross
nspection  revealed  a  relatively  well-deﬁned,  gray-white,
omogeneous,  solid  tumor  that  measured  2.5  cm  in  the
argest  diameter.
Microscopically,  the  tumor  was  composed  of  two  malig-
ant  components,  carcinoma  and  sarcoma  (Fig.  1A).  The
ormer  consisted  of  salivary  duct  adenocarcinoma  with
ypical  foci  of  comedonecrosis.  The  latter  was  composed
f  markedly  atypical,  large  polygonal  cells  with  abundant
osinophilic,  focally  foamy  cytoplasm,  with  multilobated
o  multiple  nuclei,  admixed  with  a population  of  spindle
ells  arranged  in  short  fascicles.  Mitotic  ﬁgures  were  readily
dentiﬁed;  some  were  atypical.  Thus,  the  mesenchymal
omponent  of  the  tumor  histologically  corresponded  to  MFH
Fig.  1B).  Immunohistochemistry  showed  that  the  carcino-
atous  component  was  positive  for  cytokeratin  AE1/AE3,
ytokeratin  7,  CEA,  and  HER2  (Fig.  1C).  The  sarcoma-
ous  component  was  diffusely  positive  for  vimentin.  p53
howed  focal,  nuclear  positivity  in  both  malignant  compo-
ents  (Fig.  1D).
The  multiple  sections  showed  no  evidence  of  a  pre-
xisting  PA,  and  diagnosis  of  de  novo  carcinosarcoma  of  the
arotid  gland  composed  of  salivary  duct  adenocarcinoma
nd  sarcoma  that  resembled  MFH  was  established.iscussion
alivary  gland  carcinosarcomas  are  rare,  and  therefore  a
ell  established  therapeutic  approach  is  lacking.  In  some
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Figure  1  The  tumor  was  composed  of  two  different  malignant  components,  carcinoma  (left)  and  sarcoma  (right)  (A,  ×100,  HE).  The
sarcomatous  component  morphologically  corresponded  to  malignant  ﬁbrous  histiocytoma  (B,  ×400,  HE).  Immunohistochemically,
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5the carcinoma  was  positive  for  HER2  (C,  ×100,  HER2).  p53  show
p53).
cases,  patients  were  treated  only  with  surgery,  but  the
most  common  treatment  includes  a  combination  of  surgery
and  radiotherapy.  Despite  aggressive  therapy,  local  recur-
rence  and  metastases  occur  frequently;  the  mean  survival  is
approximately  19  months.1
The  present  patient  was  additionally  treated  with  radio-
therapy  (48  Gy  in  16  fractions,  twice  a  day);  nine  months
after  surgery,  the  patient  showed  no  sign  of  local  recurrence
or  distant  metastasis.
It  is  still  unclear  whether  the  two  malignant  components
in  carcinosarcoma  of  salivary  glands  occur  by  collision  of  two
independent  tumors,  or  they  are  of  clonal  origin.  The  ﬁrst
studies  based  on  immunohistochemical  analysis  indicated
that  the  distinct  cellular  entities  reﬂect  two  indepen-
dent  neoplastic  processes.2,3 More  recent  molecular  studies
demonstrated  that  the  two  histologically  different  com-
ponents  would  result  from  a  dichotomous  differentiation
pattern  of  a  common  stem  cell,  or  by  trans-differentiation
from  one  cell  type  to  another.4--6 Fowler  et  al.4 tested
loss-of-heterozygosity  rates  at  loci  of  known  tumor  sup-
pressors  in  carcinosarcomas  and  found  a  73%  agreement
in  the  mutational  proﬁles  of  the  two  components.  Vékony
et  al.,5 using  comparative  genomic  hybridization,  observed
a  75%  homology  between  the  DNA  copy  numbers  in  epithelial
and  mesenchymal  components  of  parotid  gland  carcinosar-
coma.  Furthermore,  Völker  et  al.6 demonstrated  the  losses
on  chromosome  13  in  PA  and  the  sarcomatous  component  of
carcinosarcoma,  and  concluded  that  this  could  represent  an
early  event  in  differentiation  of  a  common  pluripotent  stem
cell  lineFinal remarks
In  the  present  case,  p53  expression  in  carcinomatous  and
sarcomatous  cells  could  indicate  identical  early  events  in  the
6cal,  nuclear  positivity  in  both  malignant  components  (D,  ×200,
arcinogenesis  of  both  malignant  components.  Therefore,
espite  morphological  and  immunohistochemical  differ-
nces  between  epithelial  and  mesenchymal  components,
he  authors  believe  that  both  elements  of  carcinosarcoma
ave  evolved  from  a  single  common  precursor  cell,  probably
 myoepithelial  cell.
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